BenchSci

BenchSci in its Series A Financing round of US$8 million

Client

BenchSci

Value

US$8 million

Service

Emerging and High Growth Companies

Date Closed

May 2018

Industry

Venture Capital

Lead Office

Toronto


 

On May 2, 2018, BenchSci announced that it has secured US$8 million in its Series A Financing round. The round was led by Montreal’s iNovia Capital with participation from Google’s AI-focused venture fund, Gradient Ventures, and return investors Golden Venture Partners, Afore Capital, Real Ventures, and Radical Ventures.

The funds will be used by BenchSci to expand its team of engineers and scientists, implement new sales and marketing programs to drive new customer acquisition, and scale its AI technology used by researchers to accelerate biomedical discoveries.

BenchSci a Toronto-based biomedical startup that uses machine learning to scan millions of data points in biomedical research papers, generating searchable results to help shorten the drug discovery process.

Osler, Hoskin & Harcourt LLP represented BenchSci with a team consisting of Chad Bayne, Justin Dharamdial and Jeremy Lin (Corporate). 


Team
Chad Bayne
Key Contact

Chad Bayne

Partner, Corporate

Justin Dharamdial

Justin Dharamdial

Associate, Corporate

Jeremy Lin

Jeremy Lin

Associate, Corporate